PreSize® Neurovascular Advanced AI Technology Supporting Life-Saving Surgical Decisions

highest validated accuracy in device deployment simulation

See publication

mins

to rehearse a case on PreSize® in real-time

shorter devices selected using PreSize® vs. without

See publication

UK Hospitals

participating in the PreSize® Neurovascular clinical impact trial ...and counting

Surgery Planning Software

PreSize® Neurovascular

AI-powered decision-support medical software, helping clinicians in real-time plan and perform neurovascular surgeries with implant devices.

Users import routine patient scans into PreSize®, which automatically builds a virtual patient-specific blood vessel model.

Users can position digital twins of different implants into the virtual blood vessel model.

PreSize® generates a best-fit device given the specific patient anatomy.

Users can make further adjustments and try out different surgical scenarios before starting the actual procedure.

With PreSize’s® powerful technology, the best-fit device for each patient is selected first time round before even starting the surgery, aiming to reduce surgical complications and improve patient outcomes.

Our mission is to provide clinicians with the powerful technology they need to make life-saving decisions and offer every patient the highest standards of care.

Mission

Our vision is to create a world where successful surgery is the norm, not the exception.

Vision

PreSize® Neurovascular

As seen on the BBC

Source: BBC Click

Careers

Join the team that makes a difference

If you are a driven individual who would like to join a team of innovators changing the future of surgery, we would love to hear from you.

See open roles

The appeal about PreSize® is that simulation of implants will play a critical role in future clinical care and trials. Study results demonstrate there is a high degree of validation and reliability in how PreSize® predicts the implant.

Prof. Ansaar Rai

Chairman of Department of Neuroradiology at West Virginia University, USA

It’s great to see an AI solution tailored to decrease pre-operative stress and improve care - I’m looking forward to participating in the prospective study that will see the use of PreSize® software in our practice and evaluate its impact.

Prof. Tufail Patankar

Consultant Interventional Neuroradiology at Leeds Teaching Hospital, UK

Oxford Heartbeat has demonstrated openness and engagement with the INR community and wants to engage in medical research, which you can see from their prospective UK multicentre study.

Dr. Jonathan Downer

Consultant Interventional Neuroradiologist at Department of Clinical Neurosciences Edinburgh, UK

Oxford Heartbeat clearly articulated a unique, commercially viable approach to an unmet health need. Crucially, it was also apparent that the company had strong visionary leadership and a diverse team with the skills and expertise to deliver a successful project.

Dr. Michael Kipping

Innovation Lead of Innovate UK Biomedical Catalyst, UK

1 in 5 of all device deployment surgeries
are currently unsuccessful.
Let us change that!

Technology

PreSize® Neurovascular

Company

Insights

Shaping the surgery of tomorrow

PreSize® Neurovascular Advanced AI Technology Supporting Life-Saving Surgical Decisions

PreSize® Neurovascular

As seen on the BBC

Join the team that makes a difference

1 in 5 of all device deployment surgeriesare currently unsuccessful.Let us change that!

1 in 5 of all device deployment surgeries
are currently unsuccessful.
Let us change that!